ロード中...
Role of Antifungal Susceptibility Testing in Non-Aspergillus Invasive Mold Infections
No clinical breakpoints are available to delineate antifungal drug efficacy in non-Aspergillus invasive mold infections (NAIMIs). In this analysis of 39 NAIMI episodes, the MIC of the first-line antifungal drug was the most important predictor of therapeutic response. For amphotericin B, an MIC of ≤...
保存先:
| 出版年: | J Clin Microbiol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4879309/ https://ncbi.nlm.nih.gov/pubmed/27008871 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.00318-16 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|